Key Metrics
4.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.91
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
0.62
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Cancer
- Western blot
- Overall survival
- Lung cancer
- Assay
- Pleural effusion
- Dexamethasone
- Cisplatin
- Hepatocellular carcinoma
- Cytidine deaminase
- Gene expression
- Principal component analysis
- Cell migration
- Breast cancer
- Colorectal cancer
- Bioinformatics
- Transcription factor
- Osteosarcoma
- Peripheral blood
- Pheochromocytoma
Journal Specifications
| Overview | |
| Publisher | AEPRESS SRO |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1954 |
| Website URL | Visit website |
Planning to publish in Neoplasma ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
USP36 plays an oncogenic role in colorectal cancer cells.
- 1 Jan 24
- Neoplasma
-
Full paper
The role of polyethylenimine-functionalized gold nanoclusters carrying plasmid CMTM5 in impeding the malignant progression of prostate cancer cells by promoting EGFR endocytosis.
- 1 Jan 24
- Neoplasma
-
Full paper
MicroRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
- 1 Jan 24
- Neoplasma
-
Full paper
The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
- 1 Jan 24
- Neoplasma
-
Full paper
Innervation density and types of nerves in prostate cancer.
- 1 Jan 24
- Neoplasma
-
Full paper
Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.
- 1 Jan 24
- Neoplasma
Scite analysis
Powered by scite_
1.7k articles received 15.9k citations see all
- 795 Supporting
- 14,774 Mentioning
- 106 Contrasting
Editorial notices
- 1 Retractions
- 0 Withdrawals
- 0 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How long has Neoplasma been actively publishing?
Neoplasma has been in operation since 1954 till date.
What is the publishing frequency of Neoplasma ?
Neoplasma published with a Bi-monthly frequency.
How many articles did Neoplasma publish last years ?
In 2023, Neoplasma published 68 articles.
What is the eISSN & pISSN for Neoplasma ?
For Neoplasma,eISSN is 1338-4317 and pISSN is0028-2685.
What is Citescore for Neoplasma ?
Citescore for Neoplasma is 4.2.
What is SNIP score for Neoplasma ?
SNIP score for Neoplasma is 0.62.
Who is the publisher of Neoplasma ?
AEPRESS SRO is the publisher of Neoplasma.